Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1AK0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $334,282
Award facts
- Contract value 100% obligated
- $334,282.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $334,282.28 to AmerisourceBergen Drug Corp for the supply of Dupixent (dupilumab) 300 mg/2 mL pen injectors. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of January 22, 2026. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Dupixent is a biologic medication used to treat conditions such as atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps, making this order critical for supporting the medical supply needs of military healthcare systems and the Defense Health Agency.
This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a maximum value of $999,999,999.00 and extends through December 2026. AmerisourceBergen, which operates under parent company Cencora, Inc., is a primary pharmaceutical distributor serving federal medical procurement needs across multiple therapeutic domains. The company's track record of fulfilling federal pharmaceutical supply contracts through competitive procurement demonstrates its capability to meet stringent government healthcare requirements for both routine and specialized medications supporting military personnel, veterans, and other federal beneficiaries.
Quick answers
Who was awarded contract SPE2DR26F1AK0?
SPE2DR26F1AK0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26F1AK0 worth?
The government has obligated $334,282 on SPE2DR26F1AK0.
Is contract SPE2DR26F1AK0 an order under another contract?
Yes. SPE2DR26F1AK0 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F1AK0 competed?
The extent of competition for SPE2DR26F1AK0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award